To include your compound in the COVID-19 Resource Center, submit it here.

International Stem Cell reports interim Phase I data for PD stem cell treatment

International Stem Cell Corp. (OTCQB:ISCO) reported interim 6-month data from the first cohort of patients in a Phase I trial to treat Parkinson's disease showing that

Read the full 269 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE